Kingworld Medicines Group Limited

SEHK:1110 Stock Report

Market Cap: HK$252.1m

Kingworld Medicines Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:1110 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Nov 24BuyHK$463,498Li Sheng ZhaoIndividual1,000,000HK$0.46
15 Nov 24BuyHK$436,103Li Sheng ZhaoIndividual1,000,000HK$0.44
17 Apr 24SellHK$509,999Shanghai Jianyi Private Equity Fund Management Co., Ltd.Company1,000,000HK$0.51

Insider Trading Volume

Insider Buying: 1110 insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1110?
Owner TypeNumber of SharesOwnership Percentage
Institutions30,191,8045.09%
Employee Share Scheme32,900,0005.55%
General Public115,715,94619.5%
Individual Insiders414,292,25069.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 80.49% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
54.1%
Li Sheng Zhao
321,096,250HK$136.5m0.18%no data
15.2%
Lok San Chan
90,060,000HK$38.3m-0.28%no data
5.55%
Kingworld Medicines Group Limited Share Award Scheme
32,900,000HK$14.0m0%no data
4.87%
Shanghai Jianyi Private Equity Fund Management Co., Ltd.
28,879,117HK$12.3m-41.8%11.13%
0.45%
Xuhua Zhou
2,676,000HK$1.1m0%no data
0.22%
Sinopharm Capital Shanghai Co., Ltd.
1,312,687HK$557.9k0%no data
0.042%
Jianbin Zhang
248,000HK$105.4k0%no data
0.036%
Cheuk Lam Wong
212,000HK$90.1k0%no data